Intent to Sole Source - Tapestri Single-Cell DNA + Protein Reagent kit v3 & Tapestri® Single-Cell DNA Cartridge Kit v3
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health, Clinical Center (NIH-CC) intends to negotiate on a sole-source basis with Mission Bio for Tapestri Single-Cell DNA + Protein Reagent kits v3 and Tapestri® Single-Cell DNA Cartridge Kits v3. This acquisition supports the Center for Cellular Engineering (CCE) in streamlining CAR T cell manufacturing and clinical research through advanced single-cell analysis. This is a Notice of Intent, not a Request for Proposal.
Purpose & Scope
The CCE requires these specialized reagent kits for single-cell DNA and protein expression analysis, utilizing their existing Mission Bio Tapestri platform. This capability is critical for developing clinical lot release efficiency, supporting phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy. The kits enable simultaneous measurement of genotype and immunophenotype at the single-cell level, essential for understanding tumor phylogenies and patient stratification in cancer treatments. The scope includes procuring multi-type single-cell DNA and protein sequencing kits and reagents, ensuring minimum shelf life (3-6 months), and providing technical support.
Contract Details
- Type: Intent to Sole Source (Special Notice)
- Vendor: Mission Bio
- Product: Tapestri Single-Cell DNA + Protein Reagent kit v3 (Part# MB03-0084) and Tapestri® Single-Cell DNA Cartridge Kit v3.
- Estimated Value: $21,380.00
- Period of Performance: Approximately May 28, 2026, to November 27, 2026 (6 months).
- Delivery: Overnight, Monday through Thursday, to the Center for Cellular Engineering (CCE), NIH/CC, Bethesda, MD.
- Special Requirements: Vendor must provide a report on cryopreserved patient cell transport, ensure temperature maintenance during shipment, and supply hard copies/PDFs of product proofs.
Set-Aside & Justification
This is a sole-source acquisition justified under 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1, citing only one responsible source. Mission Bio is identified as the only vendor capable of providing compatible reagent kits for the CCE's existing Tapestri instrument.
Response & Deadlines
This is not a Request for Proposal. However, all responsible sources that believe they can provide the required items may submit a capability statement via email to valerie.gregorio@nih.gov by 12:00 PM Eastern Standard Time on May 8, 2026. The subject line must reference NOI-OLAO-CC-26-004780. The Government will consider all responses received by the closing date.